Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

RITHM PROPERTY TRUST INC. (RPT)

  • Business News
  • June 26, 2026, 20:15 UTC
  • 6
  • 1 comments

Rithm Property Trust Inc. Declares Second Quarter 2026 Common and Preferred Stock Dividends

Market reaction Comment Full text

ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND (AFB)

  • Business News
  • June 26, 2026, 20:06 UTC
  • 6
  • 1 comments

ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND, INC. REPORTS SECOND QUARTER EARNINGS

Market reaction Comment Full text

Monopar Therapeutics Inc. (MNPR)

  • Business News
  • June 26, 2026, 20:05 UTC
  • 6
  • 1 comments

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

Market reaction Comment Full text

FASTENAL CO (FAST)

  • Business News
  • June 26, 2026, 20:05 UTC
  • 4
  • 1 comments

Fastenal Company Announces Conference Call to Review 2026 Second Quarter Earnings

Market reaction Comment Full text

LARIMAR THERAPEUTICS, INC. (LRMR)

  • Business News
  • June 26, 2026, 20:05 UTC
  • 4
  • 1 comments

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

Market reaction Comment Full text

UNIVERSE PHARMACEUTICALS INC (UPC)

  • Business News
  • June 26, 2026, 20:05 UTC
  • 4
  • 1 comments

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Market reaction Comment Full text

MONOPAR THERAPEUTICS (MNPR)

  • Business News
  • June 26, 2026, 20:05 UTC
  • 4
  • 1 comments

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

Market reaction Comment Full text

INVENTRUST PROPERTIES CORP. (IVT)

  • Business News
  • June 26, 2026, 20:03 UTC
  • 4
  • 1 comments

InvenTrust Properties Corp. Announces Second Quarter 2026 Earnings Release and Conference Call Dates

Market reaction Comment Full text

LANTHEUS HOLDINGS, INC. (LNTH)

  • Business News
  • June 26, 2026, 20:01 UTC
  • 4
  • 1 comments

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

Market reaction Comment Full text

ASCENDIS PHARMA A/S (ASND)

  • Business News
  • June 26, 2026, 20:01 UTC
  • 4
  • 1 comments

Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®

Market reaction Comment Full text
  • Previous
  • 3844
  • 3845
  • 3846
  • 3847
  • 3848
  • Next

Search

News categories

  • Technical Exchange News(14691)
  • Event(6229)
  • SEC News(393585)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239483)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin